-
SFDA issues measures on management of health food and cosmetic evaluation expertsIn order to further intensify the review of health food and cosmetics, standardize the management of the evaluation experts, and ensure that the registration of health food and cosmetics is scientif2010/8/4
-
WHO Director-General Dr Margaret Chan visits NICPBPOn July 27, 2010, Dr Margaret Chan, Director-General of the World Health Organization (WHO) and her entourage visited National Institute for the Control of Pharmaceutical and Biological Products (NI2010/8/4
-
Xeomin receives FDA approval for treatment of cervical dystoniaMerz Pharmaceuticals today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin® (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adul2010/8/4
-
Senate panel votes to end drug industry's practice of 'pay-to-delay' genericsThe Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to2010/8/2
-
FDA announces approval of vaccines for 2010-2011 US influenza seasonThe U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States. Seasonal influenza vaccine protects against three strains2010/8/2
-
FDA Advisory Committee recommends approval of AstraZeneca's ticagrelor for Acute Coronary SyndromesAstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended the FDA approve AstraZeneca's investigational drug2010/7/30
-
SFDA specifies relevant requirements for health food re-registrationIn order to further improve the re-registration of health food, the State Food and Drug Administration (SFDA) recently issued a notice to specify relevant requirements for: the China-made health food2010/7/30
-
LEO Pharma A/S voluntarily recalls sodium fusidate for injection (Fucidin)On July 26, 2010, the State Food and Drug Administration (SFDA) was informed by Invida International Trading (Shanghai) Co., Ltd. (Invida) that LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S) en2010/7/30
-
FDA accepts for filing Cladribine Tablets NDA for MSEMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine2010/7/29
-
FDA approves Tris Pharma's first-time generic of Methylphenidate Hydrochloride Oral SolutionTris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved a first-time generic of Methy2010/7/29